| |
original article |
Date |
Title |
Authors Max. 6 Authors |
| 1 |
[GO] |
2022―Mar―25 |
Lessons for Oncology From the COVID-19 Pandemic |
Thomas J. Roberts, Inga T. Lennes |
| 2 |
[GO] |
2022―Mar―25 |
Cancer Care at the Beginning of the COVID-19 Pandemic |
Nancy E. Davidson, Karen E. Knudsen, Shelley Fuld Nasso, Randall Oyer, Steve Pergam, Lara Strawbridge, Lawrence Shulman |
| 3 |
[GO] |
2022―Mar―25 |
Beyond the COVID-19 Pandemic |
Richard L. Schilsky |
| 4 |
[GO] |
2022―Mar―25 |
Patterns of Enrollment in Cancer Treatment Trials During the COVID-19 Pandemic at National Cancer Institute-Designated Cancer Centers |
Sheila A. Prindiville, Gisele A. Sarosy, David Loose, Henry Ciolino, James H. Doroshow |
| 5 |
[GO] |
2022―Mar―25 |
Lessons From the Impact of the COVID-19 Pandemic at the National Cancer Institute |
Fatima Karzai, William L. Dahut |
| 6 |
[GO] |
2022―Mar―25 |
Insights for Oncology Trials Garnered From the Rapid Development of an mRNA COVID-19 Vaccine |
Randall N. Hyer |
| 7 |
[GO] |
2022―Mar―25 |
Clinical Evidence Generation During a Pandemic |
Donna R. Rivera, Paul G. Kluetz, Kald Abdallah, Sundeep Agrawal, Derek C. Angus, Robert M. Califf, Elizabeth Garrett-Mayer, Randall Hyer, Douglas R. Lowy, Samir N. Khleif |
| 8 |
[GO] |
2022―Mar―25 |
Maintaining and Advancing Quality Cancer Care During a Global Pandemic |
Randall Alan Oyer, Lori Pierce, Christopher Lathan, Bhuvana Sagar |
| 9 |
[GO] |
2021―Aug―16 |
COVID-19 and Chronic Lymphocytic Leukemia |
Thomas Chatzikonstantinou, Yair Herishanu, Emili Montserrat, Paolo Ghia, Antonio Cuneo, Robin Foà, Lydia Scarfò |
